Aavalium targets niche or difficult-to-source/manufacture pharmaceutical products for the US market. Our product pipeline ranges from generic, 505(b)(2) to NCEs, covering a wide range of therapeutic areas and dosage forms. We aim to out-license our products to business partners for further development and/or commercialization. We continually look for partnership opportunities to co-develop new products.
Copyright © 2022 Aavalium, Inc. - All Rights Reserved.